[1]
R. A. SYAHRANI, M. LOUISA, and S. I. WANANDI, “SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS”, Int J App Pharm, vol. 11, no. 6, pp. 91-96, Dec. 2019.